• Global community
    • Language:
      • Deutsch
      • English
      • Español
      • Français
      • Português
  • 日本語コミュニティ
    Dedicated community for Japanese speakers
  • 한국 커뮤니티
    Dedicated community for Korean speakers
Exit
0

Newly Approved RSV Vaccine

Community Expert ,
May 03, 2023 May 03, 2023

Copy link to clipboard

Copied

The Food and Drug Administration approved the first-ever vaccine to combat severe respiratory syncytial virus, or RSV. 

 

Arexvy, the new vaccine developed by GlaxoSmithKline, was approved for adults 60 years and older and is 82% effective at preventing lower respiratory tract illness caused by RSV.

FDA approves first-ever RSV vaccine, shots to be available for older adults

 

 

Nancy O'Shea— Product User, Community Expert & Moderator
Alt-Web Design & Publishing ~ Web : Print : Graphics : Media

Views

62

Translate

Translate

Report

Report
Community guidelines
Be kind and respectful, give credit to the original source of content, and search for duplicates before posting. Learn more
community guidelines
no replies

Have something to add?

Join the conversation